Immuneering (IMRX) Other Working Capital Changes (2020 - 2024)
Historic Other Working Capital Changes for Immuneering (IMRX) over the last 5 years, with Q4 2024 value amounting to -$1.5 million.
- Immuneering's Other Working Capital Changes fell 176198.08% to -$1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$300102.0, marking a year-over-year increase of 2075.95%. This contributed to the annual value of -$300102.0 for FY2024, which is 2075.95% up from last year.
- As of Q4 2024, Immuneering's Other Working Capital Changes stood at -$1.5 million, which was down 176198.08% from $644549.0 recorded in Q3 2024.
- Over the past 5 years, Immuneering's Other Working Capital Changes peaked at $2.4 million during Q3 2022, and registered a low of -$1.5 million during Q4 2024.
- Its 5-year average for Other Working Capital Changes is $98477.5, with a median of -$74872.5 in 2020.
- Per our database at Business Quant, Immuneering's Other Working Capital Changes soared by 97862.83% in 2021 and then crashed by 205184.91% in 2023.
- Over the past 5 years, Immuneering's Other Working Capital Changes (Quarter) stood at -$70051.0 in 2020, then crashed by 918.63% to -$713561.0 in 2021, then soared by 100.57% to $4083.0 in 2022, then tumbled by 2051.85% to -$79694.0 in 2023, then tumbled by 1761.98% to -$1.5 million in 2024.
- Its Other Working Capital Changes stands at -$1.5 million for Q4 2024, versus $644549.0 for Q3 2024 and $788131.0 for Q2 2024.